Kemex Laboratory

Kemex is an Argentine pharmaceutical company specializing in the development, production, and commercialization of high-complexity medications, with a primary focus on oncology and hematology. Founded in 1994, the company operates state-of-the-art manufacturing facilities that comply with international GMP standards, allowing it to produce a wide range of cytotoxic and non-cytotoxic products. Kemex provides both branded generics and biosimilars to the Latin American market and other international regions. In addition to its own product line, the company offers contract manufacturing services for third-party pharmaceutical firms. Its portfolio includes essential treatments for various cancers, autoimmune diseases, and critical care conditions. The company is recognized for its commitment to quality and accessibility in the high-cost drug segment.